SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that GeneDx, a leader in genetic testing for rare diseases, is piloting Illumina's emerging constellation mapped ...
Hosted on MSN
Illumina outlines path to high single-digit revenue growth and 20% margins by 2027 amid NovaSeq X acceleration
Dhingra raised full-year 2025 revenue guidance for Greater China by $20 million to approximately $220 million. For the rest of the world, revenue growth is projected between 0.5% and 1.5% on a ...
A pair of presentations at this year’s annual meeting of the American Society of Human Genetics highlighted some of the latest capabilities from sequencing giant Illumina. At the meeting, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback